HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemokine CCL27

A CC-type chemokine with specificity for CCR10 RECEPTORS. It is constitutively expressed in the skin and may play a role in T-CELL trafficking during cutaneous INFLAMMATION.
Also Known As:
CTACK Chemokine; Cutaneous T-Cell-Attracting Chemokine; ESkine; Small Inducible Cytokine A27; CCL27, Chemokine; Chemokine, CCL27; Chemokine, CTACK; Chemokine, Cutaneous T-Cell-Attracting; Cutaneous T Cell Attracting Chemokine; T-Cell-Attracting Chemokine, Cutaneous; CCL27 Chemokine
Networked: 44 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Komine, Mayumi: 3 articles (12/2014 - 03/2003)
2. Tamaki, Kunihiko: 3 articles (12/2014 - 03/2003)
3. Vestergaard, Christian: 3 articles (12/2011 - 09/2004)
4. Monteagudo, Carlos: 2 articles (01/2021 - 01/2017)
5. Karakawa, Masaru: 2 articles (12/2014 - 12/2010)
6. Ohtsuki, Mamitaro: 2 articles (12/2014 - 12/2010)
7. Campanati, A: 2 articles (05/2012 - 12/2007)
8. Ganzetti, G: 2 articles (05/2012 - 12/2007)
9. Goteri, G: 2 articles (05/2012 - 12/2007)
10. Offidani, A: 2 articles (05/2012 - 12/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Scabies (Sarcoptic Mange)
3. Atopic Dermatitis (Atopic Eczema)
4. Inflammation (Inflammations)
5. Necrosis
12/01/2007 - "Tumour necrosis factor-alpha upregulates the expression of a cutaneous T cell-attracting chemokine (CTACK/CCL27), that promotes migration of cutaneous lymphocyte-associated antigen-positive lymphocytes into the skin. "
03/01/2009 - "Of these factors brain-derived neurotrophic factor, cutaneous T-cell-attracting chemokine, epidermal growth factor receptor, glucocorticoid-induced tumour necrosis factor receptor ligand, growth-regulated oncogene-alpha, interleukin (IL)1a, IL6, IL8, IL15, pulmonary and activation-regulated chemokine and soluble tumour necrosis factor receptor II showed a significant increase whereas migration inhibitory factor howed a decrease in concentration after exercise. "
07/01/2020 - "Serum levels of a proliferation-inducing ligand, B-cell activating factor of the TNF family, thymus and activation-regulated chemokine (chemokine (C-C motif) ligand 17) (TARC (CCl-17)), interleukin-1 receptor antagonist (IL-1RA), interleukin-1 bèta, IL-4, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-18, IL-31, interferon gamma, tumour necrosis factor alpha, vascular endothelial growth factor (VEGF), monokine induced by interferon gamma (chemokine (C-X-C motif) ligand 9), interferon gamma-induced protein 10 (C-X-C motif chemokine Ligand 10), monocyte chemoattractant protein-1 (chemokine (C-C Motif) ligand 2), macrophage inflammatory protein-1 beta (chemokine (C-C motif) ligand 4), regulated on activation, normal T cell expressed and secreted (chemokine (C-C motif) ligand 5), Cutaneous T-cell-attracting chemokine (chemokine (C-C motif) ligand 27) (CTACK (CCL-27)), thymic stromal lymphopoietin, IL-5, interleukin-1 alpha and granulocyte-colony stimulating factor were analysed by ELISA and Luminex. "

Related Drugs and Biologics

1. Interleukin-6 (Interleukin 6)
2. Granulocyte Colony-Stimulating Factor (G-CSF)
3. 6-sulfo sialyl Lewis X
4. Transforming Growth Factor alpha (TGF-alpha)
5. Chemokine CCL17
6. Chemokines
7. Biomarkers (Surrogate Marker)
8. Ligands
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10. CC Chemokines

Related Therapies and Procedures

1. Therapeutics
2. PUVA Therapy